Lipopeptide-mediated Cas9 RNP delivery: A promising broad therapeutic strategy for safely removing deep-intronic variants in ABCA4

Stakeholder insights on cost, quality, and incorporating patient voice in managed care decisions on neovascular (wet) age-related macular degeneration: Findings from the AMCP Market Insights program

Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me J Manag Care Spec Pharm. 2024 Nov;30(11-a Suppl):S1-S9. doi: 10.18553/jmcp.2024.30.11-a.s1.ABSTRACTWet age-related macular degeneration (AMD) is an acquired degeneration of the...